Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
45.5M
-
Shares change
-
-559K
-
Total reported value, excl. options
-
$2.45B
-
Value change
-
-$76.8M
-
Put/Call ratio
-
0.78
-
Number of buys
-
54
-
Number of sells
-
-92
-
Price
-
$53.91
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2018
204 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q4 2018.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.5M shares
of 62.5M outstanding shares and own 72.83% of the company stock.
Largest 10 shareholders include FMR LLC (6.59M shares), Vanguard Group Inc (3.82M shares), BlackRock Inc. (3.45M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.02M shares), WELLINGTON MANAGEMENT GROUP LLP (2.63M shares), OppenheimerFunds, Inc. (1.71M shares), STATE STREET CORP (1.54M shares), Partner Fund Management, L.P. (1.47M shares), Hillhouse Capital Advisors, Ltd. (1.43M shares), and Viking Global Investors LP (1.2M shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.